PMC:7696151 / 54228-54573
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1564","span":{"begin":190,"end":195},"obj":"Species"},{"id":"1565","span":{"begin":225,"end":231},"obj":"Species"},{"id":"1570","span":{"begin":69,"end":79},"obj":"Chemical"},{"id":"1571","span":{"begin":137,"end":140},"obj":"Chemical"},{"id":"1572","span":{"begin":249,"end":252},"obj":"Chemical"},{"id":"1575","span":{"begin":160,"end":165},"obj":"Disease"}],"attributes":[{"id":"A1564","pred":"tao:has_database_id","subj":"1564","obj":"Tax:9606"},{"id":"A1565","pred":"tao:has_database_id","subj":"1565","obj":"Tax:9606"},{"id":"A1570","pred":"tao:has_database_id","subj":"1570","obj":"MESH:D011241"},{"id":"A1571","pred":"tao:has_database_id","subj":"1571","obj":"MESH:D006886"},{"id":"A1572","pred":"tao:has_database_id","subj":"1572","obj":"MESH:D006886"},{"id":"A1575","pred":"tao:has_database_id","subj":"1575","obj":"MESH:D008180"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ng this drug with less disease activity and a lower required dose of prednisone [93]. A 5-year prospective study evaluated the effect of HCQ discontinuation on lupus progression in pregnant women. As it occurs in no pregnant people, interruption of HCQ treatment is linked to an exacerbation of the disease. Moreover, there are no statistically "}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T347","span":{"begin":86,"end":196},"obj":"Sentence"},{"id":"T348","span":{"begin":197,"end":307},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ng this drug with less disease activity and a lower required dose of prednisone [93]. A 5-year prospective study evaluated the effect of HCQ discontinuation on lupus progression in pregnant women. As it occurs in no pregnant people, interruption of HCQ treatment is linked to an exacerbation of the disease. Moreover, there are no statistically "}